DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 44 · July 2011 DOI: 10.1055/s-002-22160

Original Paper

165
Andjelkovic, M.; Jovanovic, D. B.; Zdravkovic, N.; Jankovic, S. M.: Gallbladder Emptying in Patients with Major Depression: A Case Series
169
Raposo, N.R.B.; Ferreira, A.S.; Gattaz, W.F.: Body Mass Index Increase, Serum Leptin, Adiponectin, Neuropeptide Y and Lipid Levels during Treatment with Olanzapine and Haloperidol
173
Mautone, A.; Scarone, S.; on behalf of all investigators: Transition from Ziprasidone IM to Oral Formulation in Agitated Patients with Acute Exacerbation of Schizophrenia: An Open Trial
179
Biermann, T.; Kreil, S.; Groemer, T.W.; Maihöfner, C.; Richter-Schmiedinger, T.; Kornhuber, J.; Sperling, W.: Time Perception in Patients with Major Depressive Disorder during Vagus Nerve Stimulation
183
Zhang, R.; Dong, L.; Shao, F.; Tan, X.; Ying, K.: Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis

Short Communication

189
Huber, C. G.; Schöttle, D.; Lambert, M.; Moritz, S.; Naber, D.; Schroeder, K.: Applicability of the Clinical Global Impressions-Aggression (CGI-A) Scale for Use in File Audit Trials